Infectious Diseases News and Research

RSS

B cells regulate obesity-associated inflammation and T2D through two specific mechanisms

New research from Boston University School of Medicine (BUSM) reveals that B cells regulate obesity-associated inflammation and type 2 diabetes through two specific mechanisms.

13 Mar 2013

Drug to treat leishmaniasis fails in 20% of patients, study shows

"One in five people treated for a serious form of leishmaniasis in Nepal relapse after a year," Nature reports, adding, "The finding, published in Clinical Infectious Diseases last month, is 'an alarming signal' for campaigns to eliminate the neglected disease, say researchers."

12 Mar 2013

Laboratory for Molecular Biodiscovery, KU Leuven partner for €9.5M 'PharmaSea' project

KU Leuven scientist Camila Esguerra and the Laboratory for Molecular Biodiscovery are coordinating a €9.5 million, EU-funded project to collect and study marine microbes extracted from some of the ocean's deepest, most extreme - and as-yet-unexplored -biomes.

12 Mar 2013

Pneumococcal vaccine pre-clinical development supported by £0.2 million award from Biomedical Catalyst

ImmBio (Immunobiology Ltd), a biopharmaceutical company developing innovative vaccines against serious infectious diseases, today announced that the UK government-backed Biomedical Catalyst has awarded the company approximately £0.2 million ($0.3 million) to support pre-clinical development of its pneumococcal vaccine, PnuBioVax™, which targets a wide range of strains of the bacteria.

12 Mar 2013

Many challenges exist to delivering proven interventions for preventing pediatric HIV infections

Last week's "scientific report on the 'functional cure' of a HIV-infected infant has set the world's media ablaze with discussion and speculation," Randal Kuhn, director of the Global Health Affairs Program at the University of Denver's Josef Korbel School of International Studies, and Benjamin Young, chief medical officer of the International Association of Providers of AIDS Care, write in a GlobalPost opinion piece.

12 Mar 2013

Cell phone microscope can detect intestinal worm infections in children

Scientists working in rural Tanzania have used a simple US$8 glass lens, a strip of double-sided tape, and a cheap flashlight to convert an Apple iPhone into a field microscope that can successfully detect intestinal worm infections in children, according to a study published online today by the American Journal of Tropical Medicine and Hygiene.

12 Mar 2013

Mummies provide important twist in understanding atherosclerotic vascular disease

Like nearly 4.6 million Americans, ancient hunter-gatherers also suffered from clogged arteries, revealing that the plaque build-up causing blood clots, heart attacks and strokes is not just a result of fatty diets or couch potato habits, according to new research in the journal The Lancet.

11 Mar 2013

Health-related MDGs should 'remain at the heart' of post-2015 goals

Mark Suzman, managing director for International Policy, Programs & Advocacy at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog about the Millennium Development Goals (MDGs), and how "there is a heightened sense of urgency to ensure we do everything possible to meet this ambitious deadline of 2015 -- and to make sure that a new set of goals are set that keep up the critical momentum."

11 Mar 2013

Einstein researchers to develop drug-impregnated intravaginal ring for HIV prevention in women

Researchers at Albert Einstein College of Medicine of Yeshiva University have been awarded a $12 million grant from the National Institutes of Health (NIH) to develop a drug-impregnated intravaginal ring to prevent HIV infection in women.

11 Mar 2013

New rapid laboratory test successful in identifying GBS colonization in pregnant women

A more rapid laboratory test for pregnant women to detect potentially deadly Group B strep (GBS) has been successful at identifying GBS colonization in six and a half hours, according to the results of a study from The University of Texas Health Science Center at Houston (UTHealth).

11 Mar 2013

Resuscitation with colloids not recommended

Resuscitation with colloids does not appear to decrease the risk for death, and may even increase mortality, a comprehensive study of trial data reveals.

8 Mar 2013

Patients with drug-resistant HIV can safely achieve viral suppression without NRTIs

A new multi-site study reveals patients with drug-resistant HIV can safely achieve viral suppression - the primary goal of HIV therapy - without incorporating the traditional class of HIV medications into their treatment regimen.

8 Mar 2013

APIC offers tips to stay infection-free

Beyond the obvious—steering clear of runny noses and hacking coughs—the Association for Professionals in Infection Control and Epidemiology (APIC) presents some other practical ways of staying infection-free.

8 Mar 2013

Editorial, opinion pieces react to 'functional cure' of infant born with HIV

Scientists on Sunday announced that an infant born with HIV appears to have been "functionally cured" of the virus after receiving antiretroviral therapy (ART) within 30 hours of birth.

8 Mar 2013

Study helps explain why viruses often spread through the brain in patchwork patterns

Viruses often spread through the brain in patchwork patterns, infecting some cells but missing others. New research at Washington University School of Medicine in St. Louis helps explain why. The scientists showed that natural immune defenses that resist viral infection are turned on in some brain cells but switched off in others.

8 Mar 2013

Southeast Asia's commercial trade plays a central role in spread of amphibian pathogens

A team of scientists led by the Wildlife Conservation Society (WCS) and the National University of Singapore (NUS), revealed in a new study, for the first time, the presence of the pathogenic chytrid fungus (Batrachochytrium dendrobatidis) in amphibians sampled in Singapore. And the American bullfrog may be a central player in the spread of the disease.

8 Mar 2013

ADMA Biologics initiates enrollment in RI-002 Phase III study for PIDD

ADMA Biologics, Inc. (ADMA), a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases, announced that the first patient enrolled in the pivotal Phase III clinical study of its RI-002 has been dosed.

7 Mar 2013

Infectious Diseases News and Research

B cells regulate obesity-associated inflammation and T2D through two specific mechanisms

Drug to treat leishmaniasis fails in 20% of patients, study shows

Laboratory for Molecular Biodiscovery, KU Leuven partner for €9.5M 'PharmaSea' project

Pneumococcal vaccine pre-clinical development supported by £0.2 million award from Biomedical Catalyst

Many challenges exist to delivering proven interventions for preventing pediatric HIV infections

Cell phone microscope can detect intestinal worm infections in children

Mummies provide important twist in understanding atherosclerotic vascular disease

Health-related MDGs should 'remain at the heart' of post-2015 goals

Einstein researchers to develop drug-impregnated intravaginal ring for HIV prevention in women

New rapid laboratory test successful in identifying GBS colonization in pregnant women

Resuscitation with colloids not recommended

Patients with drug-resistant HIV can safely achieve viral suppression without NRTIs

APIC offers tips to stay infection-free

Editorial, opinion pieces react to 'functional cure' of infant born with HIV

Study helps explain why viruses often spread through the brain in patchwork patterns

Southeast Asia's commercial trade plays a central role in spread of amphibian pathogens

ADMA Biologics initiates enrollment in RI-002 Phase III study for PIDD

Salk epigenetic findings may aid in crop production and study of human diseases

Link between processed meat and cardiovascular disease and cancer

St. Jude Children's Research Hospital receives donation from Warren Sulmasy

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News